Delivery Order HHSN261201300029I-HHSN26100002

Award Date 9/21/15
Potential Completion Date 8/31/20
Potential Value $16M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Cape Fear, NC 28401, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the National Cancer Institute (NCI) is a delivery order under the NIH Cancer Trials Support Unit (CTSU) Indefinite Delivery Vehicle (IDV). The $128,414.63 award was issued to PPD Development LP, a global contract research organization (CRO) that provides comprehensive clinical trial and research support services to federal agencies. The contract supports the Cancer Trials Support Unit program, which provides clinical trial management and research services to...
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $696,693.16, was awarded to PPD Development LP, a global contract research organization (CRO), to provide PPD development site and study monitoring services. The contract has no set-aside designation and is part of several indefinite delivery...
This is a $324,420.00 firm fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to PPD Development LP, a global contract research organization (CRO). The contract is for research and development services related to clinical studies in the Blueprint MedTech program, including clinical study protocol development. The contract has a 5-year period of performance from June 17, 2024 to June 16, 2029, with a base period and two option units. PPD...
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to PPD Development LP, a global contract research organization. The contract has a value of $347,500.00 and is a delivery order under the CRO Support for NCATS Bioanalytical Method Development Indefinite Delivery Contract (IDC). The contract provides clinical trial and research support services, including areas such as...
This is a $1,859,402 task order award under the National Institute of Allergy and Infectious Diseases' (NIAID) Early Phase Clinical Trial Units (EPCTU) indefinite delivery vehicle (IDV) contract. The prime contractor, PPD Development LP, is a global contract research organization that provides comprehensive clinical trial and research support services to federal agencies. This cost-plus-fixed-fee delivery order does not have a set-aside designation. PPD will perform the work in Cape Fear,...
This is a $1,737,262.53 task order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to PPD Development LP, a global contract research organization (CRO). The task order is for Phase I clinical trials in the development of neurotherapeutics and is part of the larger "Phase I Clinical Trials for Development of Neurotherapeutics" indefinite delivery/indefinite quantity (ID/IQ) contract....
This is a federal contract award to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract, valued at $139,861,060.22, is for NIAID Clinical Site Monitoring services. This is a definitive contract with a cost-plus-fixed-fee pricing type, with a period of performance through January 31, 2024. The...
This is a $5,334 cost-plus-fixed-fee delivery order task order awarded to PPD Development LP, a global contract research organization (CRO), by the National Institute on Drug Abuse (NIDA). The task order is for the preparation of pre-submission support for a pilot participant under the Blueprint MedTech (BPMT) program, which provides CRO support for regulatory affairs. The award has an ultimate completion date of December 19, 2025, and there is no set-aside designation. PPD Development LP, a...
This is a cost-plus-fixed-fee Delivery Order awarded by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to PPD Development LP, a global contract research organization (CRO). The $2,104,350.00 task order is for protocol development, database build, and bioanalytical methods development in support of a Phase I clinical trial for the neurotherapeutic drug candidate AZD4041. The award is part of a larger Indefinite Delivery/Indefinite Quantity...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $500,263.64 Delivery Order contract to PPD Development LP, a global contract research organization (CRO), for clinical site and study monitoring services in support of research partnerships for global mental health. The contract has a period of performance from September 28, 2018 to September 27, 2023 and is a labor hours type contract. PPD Development LP has provided over $500...

This is a federal contract award to PPD Development LP, a global contract research organization (CRO), by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH). The contract has an award value of $15,924,990.66 and is for the NCI's Cancer Trials Support Unit (CTSU) program, which provides administrative and other support services. The contract is a delivery order under a larger master IDIQ contract. There is no set-aside designation for this award. As a CRO, PPD Development LP provides comprehensive clinical trial and research support services to federal agencies, including expertise in areas such as regulatory affairs, clinical site monitoring, data management, and analytical testing to support the development of vaccines, therapeutics, diagnostics, and medical countermeasures. PPD has established itself as a key partner in advancing public health initiatives and medical research programs across multiple federal agencies.

Generated 4/2/25, 8:35 PM